The purchase fits Merck's plans to partly focus on acute care in hospitals. Cubist's lead drugs treats infections caused by drug-resistant bacteria. Fred Katayama reports.
01:14
01:37
01:17
00:59
00:59
01:29
01:54
01:12
01:17
01:42
00:56
01:39
02:00
02:19
01:13
01:13
01:36
01:00
01:03
00:58
00:36
01:32
01:33
01:24
01:18
00:56
01:06
01:13
01:38
02:53
01:59
01:10
00:57
00:56
01:57
00:52
01:17
01:35
01:08
01:25
01:37
01:17
01:29
00:56
01:00
01:03
00:58
00:39
01:59
01:39
00:58
01:07
00:46
00:22
01:21
00:46
01:27
00:53
01:00
00:40
01:39
01:18
02:14
01:00
01:01
01:10
01:42
01:08
01:00
01:31
01:37
01:34
01:27
00:23
01:21
00:52
02:00
01:05
01:44
01:29
01:15
01:18
03:11
01:44
01:34
01:15
01:20
01:20
03:01
00:51
00:50
01:26
01:18
02:49
00:59
02:19
02:19
01:59
00:49
00:38